bpc 157 daily dose for men BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or Peptide BPC-157 - Does It
Description
No downtime

It mimics a fragment of the native gastric protein, which may allow it to interact with receptors involved in tissue repair without provoking a strong immune response

1/31/85: Patient complaining of slight headache
One reason 5-Amino-1MQ has generated interest is its oral bioavailability , meaning it may be effectively used in capsule form in certain protocols
